Biovail hikes dividend, shifts strategy
Reuters - in an effort to cut costs across the organization, and will take charges because of that. The stock rose more than 10 percent, even though Biovail also said the likely introduction of generic versions of its Wellbutrin XL anti-depression drug
Source: today.reuters.com
UPDATE 4-Biovail stock up on dividend hike, strategy shift
Reuters - The stock rose more than 10 percent, even though Biovail said the likely introduction of generic versions of its Wellbutrin XL anti-depression drug would hit 2007 results. "That (the generic drugs) will have a significant impact on us," Chief
Source: today.reuters.com
Click here for more information about depression screening depression screening
<< Home